Home
Low-cost semaglutide and tirzepatide pathways

Affordable GLP-1 Weight Loss in NYC, NJ and PA

W8MD offers affordable GLP-1 weight loss options through active offices in Philadelphia and Brooklyn, with service for eligible regional patients.

  • Physician-supervised medical weight loss
  • Semaglutide and tirzepatide options
  • Insurance accepted for qualifying visits
  • Self-pay GLP-1 programs available
  • Sleep apnea screening and home sleep studies
  • Long-term maintenance support
Affordable GLP-1 Weight Loss in NYC, NJ and PA
W8MD combines medical evaluation, nutrition, medication options, sleep screening and long-term maintenance.
Physician-supervised care

Affordable GLP-1 care across W8MD service areas

W8MD helps patients choose a medically appropriate path instead of relying on a one-size-fits-all diet or a medication-only shortcut. The program may include GLP-1 injections, oral or traditional prescription weight-loss medications, structured nutrition, sleep evaluation, meal replacements and follow-up visits.

Patients can ask about brand-name medications such as Wegovy and Zepbound, lower-cost semaglutide and tirzepatide pathways when available and appropriate, and non-GLP-1 options such as phentermine, Qsymia, Contrave, Saxenda, orlistat and other selected therapies.

  • Medical and medication-history review before treatment
  • Transparent discussion of insurance and self-pay options
  • Side-effect monitoring and dose adjustment when appropriate
  • Sleep apnea screening when symptoms or obesity-related risk is present
  • Maintenance planning to help reduce weight regain
Treatment options

Modern Weight Loss and Sleep Medicine Options at W8MD

Care is individualized by eligibility, medical history, insurance coverage, budget and treatment goals.

Semaglutide GLP-1 Programs

Semaglutide can help reduce appetite and increase fullness when paired with diet and activity. W8MD self-pay starting-dose programs may begin at $59.99 per week and up for eligible patients.

  • Wegovy evaluation when appropriate
  • Lower-cost semaglutide pathways when available
  • Nutrition and maintenance support

Tirzepatide and Zepbound

Tirzepatide acts at both GIP and GLP-1 receptors. W8MD self-pay starting-dose programs may begin at $69.99 per week and up for eligible patients.

  • Zepbound evaluation for obesity
  • Zepbound OSA evaluation when clinically eligible
  • Prior-authorization support when covered

Traditional Prescription Options

Some patients may do better with oral medications or combination approaches after careful screening.

  • Phentermine or Adipex
  • Qsymia, Contrave, Saxenda or orlistat
  • Meal replacements and structured nutrition

Sleep Apnea Screening

Weight and sleep are closely connected. W8MD evaluates snoring, daytime sleepiness and obesity-related sleep apnea risk.

  • Home sleep testing when appropriate
  • CPAP/BiPAP/APAP support
  • Weight loss as part of sleep-health care

Insurance and Self-Pay

W8MD accepts many insurance plans for qualifying visits and offers transparent self-pay alternatives when insurance does not cover medication.

  • Medication coverage varies by plan
  • Prior authorization when available
  • Self-pay pricing varies by dose and source

Long-Term Maintenance

W8MD emphasizes weight maintenance, plateau strategies, ongoing follow-up and prevention of weight regain.

  • Dose reassessment
  • Protein and activity guidance
  • Relapse-prevention planning
Medication comparison

GLP-1 and Prescription Weight Loss Options

OptionRole in careW8MD discussion points
SemaglutideWeekly GLP-1 option used for appetite and satiety support.Self-pay starting-dose programs from $59.99/week and up for eligible patients; Wegovy evaluation when covered or preferred.
TirzepatideWeekly dual GIP/GLP-1 option used for chronic weight management.Self-pay starting-dose programs from $69.99/week and up for eligible patients; Zepbound evaluation including OSA indication when appropriate.
Traditional medicationsOral or injectable alternatives for selected patients.Phentermine, Qsymia, Contrave, Saxenda, orlistat and other options based on clinical suitability.
Sleep medicineHome sleep study, sleep apnea screening and PAP support.Important for patients with snoring, fatigue, high BMI, hypertension or daytime sleepiness.
★★★★★
“Truly a life changer.” D.M. reported losing 87 pounds in 10 months with W8MD, with minimal hunger and fewer cravings. The original W8MD story also notes that D.M. lost approximately 100 pounds and maintained the result for years.
D.M. — W8MD patient success story

Individual results vary. Testimonials describe individual experiences and do not guarantee the same outcome for another patient.

Read more W8MD success stories

Active W8MD offices

Philadelphia and Brooklyn Medical Weight Loss Offices

W8MD focuses on active offices in Northeast Philadelphia and Brooklyn, New York. New Jersey, Delaware, Connecticut and nearby patients may be served through these offices or eligible telehealth when clinically and legally appropriate.

Philadelphia, Pennsylvania

215-676-2334

W8MD Weight Loss, Sleep & MedSpa
1718 Welsh Road, 2nd Floor, Suite C
Philadelphia, PA 19115

Serving Northeast Philadelphia, Greater Philadelphia, Bucks County, Montgomery County, South Jersey and Delaware.

Brooklyn, New York City

718-946-5500

W8MD Weight Loss, Sleep & MedSpa
2632 East 21st Street, Suite L3
Brooklyn, NY 11235
Fax: 718-946-5502

Serving Brooklyn, Queens, Manhattan, Staten Island, the Bronx, Long Island, North Jersey and eligible NYC-area patients.

FAQ

Frequently Asked Questions

How much do GLP-1 shots cost at W8MD?

For eligible self-pay patients, semaglutide programs may start at $59.99 per week and up, and tirzepatide programs may start at $69.99 per week and up. Final cost varies by dose, medication source, pharmacy, visit type, insurance coverage, shipping, lab needs and program details.

Does W8MD accept insurance?

W8MD accepts many insurance plans for qualifying medical visits. Medication coverage is separate and varies by plan, deductible, copay, formulary and prior-authorization requirements.

Are compounded GLP-1 medications the same as Wegovy or Zepbound?

No. Compounded medications are not FDA-approved and are not the same as FDA-approved brand-name products. W8MD discusses available and clinically appropriate options with each patient.

Can weight loss help sleep apnea?

Weight loss may improve obesity-related obstructive sleep apnea for some patients, but it does not replace proper testing or prescribed therapy. W8MD can screen for sleep apnea and arrange testing when appropriate.

Ready to Discuss Affordable GLP-1 Weight Loss in NYC, NJ and PA?

Talk with W8MD about GLP-1 medications, traditional prescription options, sleep apnea screening, nutrition and long-term maintenance.

Request a W8MD Consultation

Use the form below to ask about GLP-1 injections, prescription weight loss medications, sleep apnea screening, home sleep studies, insurance-friendly visits, or self-pay options.

    Please do not submit urgent medical concerns, Social Security numbers, insurance ID numbers, or highly sensitive medical details through this form. If this is a medical emergency, call 911.

    Medical, medication, pricing and insurance disclaimer: This page is for general informational and promotional purposes only and does not replace individualized medical advice, diagnosis or treatment. Prescription treatment requires a medical evaluation, and a consultation does not guarantee that a medication will be prescribed. Medication availability, dose, pharmacy source, compounded-drug availability, pricing, insurance participation, telehealth eligibility, copay, deductible, shipping, lab needs and program charges may change. Compounded medications are not FDA-approved and are not the same as FDA-approved brand-name products such as Wegovy or Zepbound. Individual results vary.

    Start typing and press Enter to search

    Shopping Cart